Crossmark

Machine learning for the prediction of three-year survival in locally advanced breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound imaging

Crossref DOI link: https://doi.org/10.1038/s41598-026-51550-7

Published Online: 2026-05-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Falou, Omar

Sannachi, Lakshmanan

Czarnota, Gregory J.

Kolios, Michael C.
Funding

Funding for this research was provided by:

Terry Fox Foundation

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council of Canada
License Information

Text and Data Mining valid from 2026-05-05

Accepted Manuscript valid from 2026-05-05
More Information

Article History

Received: 16 July 2025

Accepted: 28 April 2026

First Online: 5 May 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below